WASHINGTON — The medical technology sector has been plagued recently by myriad issues that have conspired to make the industry a tough sell to the investment community. Iian Scott, lead analyst for Ernst & Young's (EY; London) Lifescience group, called the three primary problems a "perfect storm for the industry." Read More
